Application of Evolving Evidence in Mantle Cell Lymphoma: Therapeutic Strategies Using BTK Inhibitors

Understand recent data and expert opinions for the optimal use of BTK inhibitors in the treatment of MCL in your clinical practice, featuring an overview of current therapies and optimization of frontline treatment strategies, through an on-demand webcast with accompanying slides and expert-written ClinicalThought commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca